[Clinical studies on glucocorticoid-induced osteoporosis].
Tanaka
I
I
Oshima
H
H
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001862:Bone Resorption / Q000139:chemically induced; D002118:Calcium / Q000378:metabolism; D002454:Cell Differentiation / Q000187:drug effects; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007408:Intestinal Absorption / Q000187:drug effects; D007684:Kidney Tubules / Q000378:metabolism; D010006:Osteoblasts / Q000166:cytology; D010010:Osteoclasts / Q000166:cytology; D010012:Osteogenesis / Q000187:drug effects; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D010906:Pituitary Hormone-Releasing Hormones / Q000378:metabolism
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D010906:Pituitary Hormone-Releasing Hormones; D002118:Calcium